Related Experiment Video
Updated: Jun 20, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
[A clinical study of five cases demonstrating relapsing polychondritis]
Rumi Minami1, Tomoya Miyamura, Masataka Nakamura
1Department of Internal Medicine and Rheumatology, Clinical Research Institute, National Hospital Organization, Kyushu Medical Center.
Relapsing polychondritis (RP) is a rare autoimmune disease affecting cartilage. Early diagnosis with anti-type II collagen antibodies and prompt steroid treatment are crucial for managing this condition.
Area of Science:
- Rheumatology
- Immunology
- Rare Diseases
Background:
- Relapsing polychondritis (RP) is a rare multisystemic disease.
- Characterized by recurrent inflammation of cartilaginous structures.
- Potential autoimmune etiology.
Observation:
- Study analyzed five patients (4 males, 1 female) with RP.
- Symptoms included auricular chondritis, arthritis, and laryngeal/tracheobronchial involvement.
- One patient presented with MAGIC syndrome.
Findings:
- Antibodies to type II collagen detected in 4 patients, correlating with C-reactive protein levels.
- Corticosteroid therapy showed initial symptom improvement in all patients.
- Three patients experienced recurrence upon corticosteroid reduction, managed with pulse therapy or immunosuppressants.
Implications:
- Early diagnosis of relapsing polychondritis is vital.
- Anti-type II collagen antibodies aid in diagnosis.
- Prompt steroid therapy and potential immunosuppressive treatment are key to preventing organ damage.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Pericarditis II: Clinical Features and Diagnostic Tests
Pericarditis I: Introduction
Rheumatic Heart Disease I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
